Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 8-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues: |
| Catalysts | | | 863.1 | 820.9 | 758.9 | 761.2 | 757.9 | 762.2 |
| Performance Chemicals | | | | | 1,207.5 | 1,128.3 | 1,101.4 | 1,060.8 |
| All Other | | | | | | | | 182.6 |
| Other | | | 3,725.4 | 2,583.5 | 1,634.6 | 1,363.3 | 1,317.1 | 1,223.5 |
| Total revenues | | | 5,593.3 | 4,332.1 | 3,626.4 | 3,328.0 | 3,312.9 | 3,229.2 |
| Revenue growth [+] | | | 68.8% | 34.2% | 12.6% | 6.4% | 2.2% | -4.3% |
| Catalysts | | | 13.9% | 7.7% | -6.4% | -4.6% | -14.3% | -19.6% |
| Performance Chemicals | | | | | 19.1% | 16.9% | 16.5% | 10.0% |
| All Other | | | | | | | | -9.1% |
| Cost of goods sold | | | 3,283.5 | 2,816.8 | 2,443.1 | 2,330.0 | 2,286.1 | 2,197.6 |
| Gross profit | | | 2,309.9 | 1,515.3 | 1,183.3 | 998.0 | 1,026.8 | 1,031.6 |
| Gross margin | | | 41.3% | 35.0% | 32.6% | 30.0% | 31.0% | 31.9% |
| Selling, general and administrative [+] | | | 499.3 | 468.3 | 460.9 | 441.5 | 443.1 | 435.7 |
| Sales and marketing | | | 376.0 | 345.0 | 337.6 | | 318.2 | 310.8 |
| General and administrative | | | | | | 123.3 | | |
| Research and development | | | 64.0 | 58.9 | 55.5 | 54.0 | 57.3 | 57.5 |
| Equity in earnings | | | 483.0 | 251.9 | 141.7 | 95.8 | 105.9 | 104.3 |
| Other operating expenses | | | | | -289.8 | -298.2 | -438.7 | -441.2 |
| EBITDA [+] | | | 2,373.0 | 1,367.5 | 1,356.8 | 1,150.5 | 1,318.5 | 1,328.0 |
| EBITDA growth | | | 80.0% | 3.0% | 48.6% | 30.0% | 52.5% | 46.4% |
| EBITDA margin | | | 42.4% | 31.6% | 37.4% | 34.6% | 39.8% | 41.1% |
| Depreciation | | | 271.7 | 261.7 | 246.1 | 247.8 | 247.5 | 244.1 |
| EBITA | | | 2,101.4 | 1,105.9 | 1,110.7 | 902.7 | 1,071.0 | 1,083.9 |
| EBITA margin | | | 37.6% | 25.5% | 30.6% | 27.1% | 32.3% | 33.6% |
| Amortization of intangibles | | | 11.8 | 6.2 | 12.2 | 6.2 | | |
| EBIT [+] | | | 2,089.5 | 1,099.7 | 1,098.5 | 896.5 | 1,071.0 | 1,083.9 |
| EBIT growth | | | 95.1% | 1.5% | 63.3% | 37.3% | 67.9% | 58.4% |
| EBIT margin | | | 37.4% | 25.4% | 30.3% | 26.9% | 32.3% | 33.6% |
| Non-recurring items [+] | | | | | | 2.3 | 10.3 | 11.8 |
| Asset impairment | | | | | | 2.3 | 10.3 | 11.8 |
| Interest expense | | | 104.2 | 79.7 | 45.4 | 61.5 | 75.3 | 89.4 |
| Interest expense | | | 104.2 | 79.7 | 45.4 | 61.5 | 75.3 | 89.4 |
| Other income (expense), net [+] | | | -422.3 | -842.3 | -740.9 | -699.1 | -795.3 | -154.2 |
| Gain (loss) on sale of business | | | | | -287.6 | -296.0 | -428.4 | -429.4 |
| Other | | | 60.8 | -590.4 | -599.2 | -603.3 | -689.4 | -49.9 |
| Pre-tax income | | | 1,562.3 | 176.2 | 310.0 | 133.6 | 190.1 | 828.5 |
| Income taxes | | | 381.5 | 69.9 | 87.9 | 29.4 | 4.3 | 149.6 |
| Tax rate | | | 24.4% | 39.7% | 28.3% | | 2.3% | 18.1% |
| Minority interest | | | 110.3 | 94.6 | 82.4 | 76.3 | 79.5 | 79.9 |
| Net income | | | 1,553.5 | 263.6 | 281.4 | 123.7 | 212.1 | 703.2 |
| Net margin | | | 27.8% | 6.1% | 7.8% | 3.7% | 6.4% | 21.8% |
| |
| Basic EPS [+] | | | $13.30 | $2.26 | $2.41 | $1.07 | $1.87 | $6.36 |
| Growth | | | 609.8% | -64.5% | -28.5% | -69.7% | -47.8% | 54.0% |
| Diluted EPS [+] | | | $13.23 | $2.25 | $2.40 | $1.07 | $1.87 | $6.33 |
| Growth | | | 608.6% | -64.5% | -28.5% | -69.7% | -47.9% | 53.7% |
| |
| Dividends per share [+] | $0.00 | $0.00 | $1.58 | $1.57 | $1.57 | $1.56 | $1.56 | $1.55 |
| Growth | -100.0% | -100.0% | 1.3% | 1.3% | 1.3% | 1.3% | 2.1% | 3.0% |
| |
| Shares outstanding (basic) [+] | | | 116.8 | 116.7 | 116.7 | 115.6 | 113.2 | 110.5 |
| Growth | | | 3.2% | 5.6% | 8.1% | 8.7% | 6.6% | 4.2% |
| Shares outstanding (diluted) [+] | | | 117.4 | 117.2 | 117.1 | 116.1 | 113.6 | 111.1 |
| Growth | | | 3.4% | 5.5% | 8.1% | 8.8% | 6.6% | 4.4% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|